HR+/HER2− breast cancer

Open Access
Calcification-associated molecular traits and therapeutic strategies in hormone receptor-positive HER2-negative breast cancer
Yuwei Li, Yuzheng Xu, Caijin Lin, Xi Jin, Ding Ma and Zhiming Shao

Cancer Biology & Medicine May 2024, 21 (5) 400-415; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0492
You have access
Combined chemo-endocrine therapy as a potential new option for HR+/HER2− advanced breast cancer: a prospective study of fulvestrant plus oral vinorelbine
Xue Wang, Jian Yue, Yikun Kang, Zhong Dai, Jie Ju, Jiayu Wang, Pin Zhang, Fei Ma, Binghe Xu and Peng Yuan

Cancer Biology & Medicine April 2023, 20 (4) 287-296; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0702

Main menu